ABCG2-mediated SN-38 efflux drives resistance to Sacituzumab govitecan in urothelial carcinoma. Academic Article uri icon

Overview

publication date

  • January 13, 2026

Identity

Scopus Document Identifier

  • 105027848379

Digital Object Identifier (DOI)

  • 10.1016/j.canlet.2026.218254

PubMed ID

  • 41539407

Additional Document Info

volume

  • 640